Researchers at Balgrist University Hospital have responded to critics of their infant cervical spine study, arguing that ...

Jayden Reed was taken off the field on a stretcher in Week 2 against the Jets. On just the second play of the game, Reed was tackled on a screen pass and was twisted around. There didn’t appear to be ...

In the first quarter of 2026, six public miners sold 32,000 Bitcoin, surpassing their total sales for all of 2025 and setting a new quarterly record, exceeding the 20,000 coins sold during the ...

Orion Family Spinal Center has updated an informational guide describing its approach to neck pain relief through precise upper cervical chiropractic care. The updated guide addresses how neck ...

Orion Family Spinal Center has updated an informational guide describing its approach to neck pain relief through precise upper cervical chiropractic care. The updated guide addresses how neck ...

A square peg doesn't fit a round hole. But what if the peg could change the shape of the hole? A newly developed drug molecule can do something surprisingly similar when binding to its target protein, ...

Valley View has partnered with Grand River Health to expand access to specialized spine care for patients in Rifle and surrounding communities. Through the partnership, Valley View Spine Center is now ...

FDA cleared apitegromab-mstn for SMA ≥2 years on background SMN2 therapy, establishing a complementary, muscle-directed strategy to pair with motor neuron–targeted SMN restoration. SAPPHIRE randomly ...

Netflix informed Fox News Digital Thursday it did not intend to reference Turning Point USA founder Charlie Kirk's assassination in a recent post about almost suffering "a neck injury" on its UK & ...

A multicenter randomized clinical trial led by researchers from the Pain Outcomes Lab at Wake Forest University School of Medicine found that high-frequency spinal cord stimulation significantly ...

Ruben Mesa, MD, discusses the FDA approval of ropeginterferon alfa-2b-njft, the first new essential thrombocythemia therapy in nearly 30 years. Mesa, principal investigator of the SURPASS ET trial, ...